Health officials are reminding the public that antibiotics are ineffective against respiratory infections caused by viruses, ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The findings come on the cusp of the Northern Hemisphere flu and respiratory syncytial virus seasons and rising US COVID-19 ...

Upper respiratory infections (URIs) are some of the most common infections and are caused by a variety of pathogens. Treatment for URIs is usually symptomatic only, if needed, unless a person also has ...

aDepartment of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent ...

Despite patients with chronic respiratory diseases commonly being ... Among COPD patients, the effectiveness of PPV in preventing pneumonia and/or acute infective exacerbations is unclear.

Respiratory virus data included in the interactive data application is up-to-date as of September 14, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

respiratory syncytial virus (RSV). RSV typically causes mild, cold-like symptoms, shortness of breath, tiredness and fever, but can also lead to severe lung infections like pneumonia and infant ...